Literature DB >> 35044207

Loss of the E6AP Ubiquitin Ligase Induces p53-Dependent Phosphorylation of Human Papillomavirus 18 E6 in Cells Derived from Cervical Cancer.

Arushi Vats1, Neva Skrabar2, Giannino Del Sal1,3,4, Lawrence Banks1.   

Abstract

Cancer-causing human papillomavirus (HPV) E6 oncoproteins contain a well-characterized phosphoacceptor site within the PDZ (PSD-95/Dlg/ZO-1) binding motif (PBM) at the C terminus of the protein. Previous studies have shown that the threonine or serine residue in the E6 PBM is subject to phosphorylation by several stress-responsive cellular kinases upon the induction of DNA damage in cervical cancer-derived cells. However, there is little information about the regulation of E6 phosphorylation in the absence of DNA damage and whether there may be other pathways by which E6 is phosphorylated. In this study, we demonstrate that loss of E6AP results in a dramatic increase in the levels of phosphorylated E6 (pE6) despite the expected overall reduction in total E6 protein levels. Furthermore, phosphorylation of E6 requires transcriptionally active p53 and occurs in a manner that is dependent upon DNA-dependent protein kinase (DNA PK). These results identify a novel feedback loop, where loss of E6AP results in upregulation of p53, leading to increased levels of E6 phosphorylation, which in turn correlates with increased association with 14-3-3 and inhibition of p53 transcriptional activity. IMPORTANCE This study demonstrates that the knockdown of E6AP from cervical cancer-derived cells leads to an increase in phosphorylation of the E6 oncoprotein. We show that this phosphorylation of E6 requires p53 transcriptional activity and the enzyme DNA PK. This study therefore defines a feedback loop whereby activation of p53 can induce phosphorylation of E6 and which in turn can inhibit p53 transcriptional activity independently of E6's ability to target p53 for degradation.

Entities:  

Keywords:  DNA PK; E6; E6AP; HPV; PBM; p53

Mesh:

Substances:

Year:  2022        PMID: 35044207      PMCID: PMC8941904          DOI: 10.1128/JVI.01503-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  42 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation.

Authors:  M T Pickering; T F Kowalik
Journal:  Oncogene       Date:  2006-02-02       Impact factor: 9.867

3.  Papillomavirus E6 PDZ interactions can be replaced by repression of p53 to promote episomal human papillomavirus genome maintenance.

Authors:  Nicole Brimer; Scott B Vande Pol
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  Identification of E6AP-independent degradation targets of HPV E6.

Authors:  Arushi Vats; Jayashree Thatte; Lawrence Banks
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

5.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.

Authors:  M Scheffner; B A Werness; J M Huibregtse; A J Levine; P M Howley
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

6.  Cancer-causing human papillomavirus E6 proteins display major differences in the phospho-regulation of their PDZ interactions.

Authors:  Siaw Shi Boon; Vjekoslav Tomaić; Miranda Thomas; Sally Roberts; Lawrence Banks
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

7.  Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.

Authors:  D L Jones; D A Thompson; K Münger
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

Review 8.  Human papillomavirus E6 and E7: What remains?

Authors:  Arushi Vats; Oscar Trejo-Cerro; Miranda Thomas; Lawrence Banks
Journal:  Tumour Virus Res       Date:  2021-02-08

9.  The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18.

Authors:  Craig P Delury; Elizabeth K Marsh; Claire D James; Siaw Shi Boon; Lawrence Banks; Gillian L Knight; Sally Roberts
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

Review 10.  Upsetting the Balance: When Viruses Manipulate Cell Polarity Control.

Authors:  Miranda Thomas; Lawrence Banks
Journal:  J Mol Biol       Date:  2018-04-20       Impact factor: 5.469

View more
  2 in total

1.  Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).

Authors:  Arushi Vats; Oscar Trejo-Cerro; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

Review 2.  Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities.

Authors:  Lilian Makgoo; Salerwe Mosebi; Zukile Mbita
Journal:  Front Mol Biosci       Date:  2022-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.